| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |